{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:59:37Z","timestamp":1789750777151,"version":"4.0.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.bpobgyn.2011.10.006","type":"journal-article","created":{"date-parts":[[2011,11,11]],"date-time":"2011-11-11T20:38:35Z","timestamp":1321043915000},"page":"65-76","source":"Crossref","is-referenced-by-count":55,"title":["Antiphospohlipid syndrome in obstetrics"],"prefix":"10.1016","volume":"26","author":[{"given":"Alvaro","family":"Danza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Ruiz-Irastorza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munther","family":"Khamashta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2011.10.006_bib1","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(10)60709-X","article-title":"Antiphospholipid syndrome","volume":"376","author":"Ruiz-Irastorza","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/archinte.164.1.77","article-title":"High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus","volume":"164","author":"Ruiz-Irastorza","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib3","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1136\/bmj.c2541","article-title":"Diagnosis and management of the antiphospholipid syndrome","volume":"340","author":"Cohen","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib4","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib5","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1136\/ard.2008.093179","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients","volume":"68","author":"Cervera","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib6","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1056\/NEJMcp1005330","article-title":"Clinical practice. Recurrent miscarriage","volume":"363","author":"Branch","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.hoc.2007.10.008","article-title":"Antiphospholipid syndrome in pregnancy","volume":"22","author":"Bick","year":"2008","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib8","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1177\/0961203310361490","article-title":"Obstetric antiphospholipid syndrome: current uncertainties should guide our way","volume":"19","author":"Branch","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib9","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/oxfordjournals.humrep.a136224","article-title":"Antiphospholipid antibodies and beta 2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach","volume":"10","author":"Rai","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib10","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(10)60279-6","article-title":"Pre-eclampsia","volume":"376","author":"Steegers","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11926-007-0035-9","article-title":"Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome?","volume":"9","author":"Clark","year":"2007","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib12","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/bmj.287.6399.1088","article-title":"Thrombosis, abortion, cerebral disease and the lupus anticoagulant","volume":"287","author":"Hughes","year":"1983","journal-title":"Br Med J"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/OGX.0b013e3181c97809","article-title":"Is obstetric antiphospholipid syndrome a primary nonthrombotic, proinflammatory, complement-mediated disorder related to antiphospholipid antibodies?","volume":"65","author":"Alijotas-Reig","year":"2010","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.medcli.2009.05.027","article-title":"The complement system as a main actor in the pathogenesis of obstetric antiphospholipid syndrome","volume":"134","author":"Alijotas-Reig","year":"2010","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1191\/096120301667486047","article-title":"Placentation, antiphospholipid syndrome and pregnancy outcome","volume":"10","author":"Stone","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1084\/jem.200116116","article-title":"Complement C3 activation is required for antiphospholipid antibody-induced fetal loss","volume":"195","author":"Holers","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib17","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/nm1121","article-title":"Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation","volume":"10","author":"Girardi","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib18","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1177\/0961203308094994","article-title":"Tissue factor in antiphospholipid antibody-induced pregnancy loss: a pro-inflammatory molecule","volume":"17","author":"Girardi","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib19","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/0961203310361485","article-title":"The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis","volume":"19","author":"Rand","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib20","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2009-04-213520","article-title":"Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug","volume":"115","author":"Rand","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/03009749609069986","article-title":"Thrombosis and systemic lupus erythematosus: the Hopkins Lupus Cohort perspective","volume":"25","author":"Petri","year":"1996","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib22","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/0961203306071872","article-title":"Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus","volume":"15","author":"Ruiz-Irastorza","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib23","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/rheumatology\/41.8.924","article-title":"A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome","volume":"41","author":"Erkan","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1740-2557-6-3","article-title":"Antiphospholipid (Hughes) syndrome: beyond pregnancy morbidity and thrombosis","volume":"6","author":"Mialdea","year":"2009","journal-title":"J Autoimmune Dis"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000093564","article-title":"The diagnosis of the antiphospholipid syndrome","volume":"35","author":"Pengo","year":"2006","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib27","first-page":"2214","article-title":"Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis","volume":"33","author":"Opatrny","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib28","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.thromres.2008.03.012","article-title":"Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy","volume":"123","author":"Ruffatti","year":"2009","journal-title":"Thromb Res"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib29","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/acr.20098","article-title":"Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcome","volume":"62","author":"Ruffatti","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/0961203309347794","article-title":"Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome","volume":"9","author":"Bramham","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib31","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/0961203309361483","article-title":"Towards evidence-based treatment of thrombotic antiphospholipid syndrome","volume":"19","author":"Derksen","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib32","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/GRF.0b013e3181eb3297","article-title":"Stillbirth workup and delivery management","volume":"53","author":"Silver","year":"2010","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib33","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1182\/blood-2007-12-129627","article-title":"How we diagnose the antiphospholipid syndrome","volume":"115","author":"Giannakopoulos","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib34","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/art.23109","article-title":"A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies","volume":"57","author":"Ruiz-Irastorza","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib35","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/0961203310395803","article-title":"Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies","volume":"20","author":"Ruiz-Irastorza","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/art.24232","article-title":"Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies","volume":"61","author":"Tektonidou","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib37","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0002-9378(89)90468-7","article-title":"Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody","volume":"160","author":"Lockshin","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib38","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/0002-9378(93)90410-K","article-title":"Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients","volume":"169","author":"Silver","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib39","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/0002-9378(92)91596-3","article-title":"Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin","volume":"166","author":"Cowchock","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib40","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijgo.2008.11.010","article-title":"Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome","volume":"104","author":"Dendrinos","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib41","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.314.7076.253","article-title":"Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)","volume":"314","author":"Rai","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib42","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0029-7844(02)02165-8","article-title":"Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment","volume":"100","author":"Farquharson","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib43","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nrrheum.2010.42","article-title":"Effectiveness of treatments for pregnant women with APS","volume":"6","author":"Gelber","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib44","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3899\/jrheum.080763","article-title":"Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial","volume":"36","author":"Laskin","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib45","first-page":"CD002859","article-title":"Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant","volume":"2","author":"Empson","year":"2005","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib46","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/rheumatology\/kep373","article-title":"Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression","volume":"49","author":"Mak","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib47","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/AOG.0b013e3181deba40","article-title":"Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis","volume":"115","author":"Ziakas","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib48","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/AOG.0b013e3181f4e012","article-title":"Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss","volume":"116","author":"Clark","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib49","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.rdc.2006.05.007","article-title":"Management of antiphospholipid syndrome in pregnancy","volume":"32","author":"Petri","year":"2006","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib50","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.rdc.2007.02.003","article-title":"Antiphospholipid syndrome in pregnancy","volume":"33","author":"Ruiz-Irastorza","year":"2007","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib51","doi-asserted-by":"crossref","first-page":"844S","DOI":"10.1378\/chest.08-0761","article-title":"American College of Chest Physicians. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Bates","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib52","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0889-857X(05)70226-X","article-title":"Management of pregnancy in antiphospholipid syndrome","volume":"27","author":"Shehata","year":"2001","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/ar1957","article-title":"Anti-inflammatory and immunosuppressive drugs and reproduction","volume":"8","author":"\u00d8stensen","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib54","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/AAP.0b013e3181c15c70","article-title":"American College of Chest Physicians. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition)","volume":"35","author":"Horlocker","year":"2010","journal-title":"Reg Anesth Pain Med"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib55","doi-asserted-by":"crossref","first-page":"299S","DOI":"10.1378\/chest.08-0675","article-title":"The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Douketis","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib56","unstructured":"Royal College of Obstetricians and Gynaecologists. Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. Green Top Guideline no. 37; November 2009."},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib57","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1191\/096120301682430168","article-title":"Lupus pregnancy: is heparin a risk factor for osteoporosis?","volume":"10","author":"Ruiz-Irastorza","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0961203309353171","article-title":"Low-molecular-weight heparin-induced osteoporosis and osteoporotic fractures: a myth or an existing entity?","volume":"19","author":"Lefkou","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib59","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/ard.2003.019000","article-title":"The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women","volume":"64","author":"Le Thi Thuong","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib60","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/bmj.332.7539.463","article-title":"Management of pre-eclampsia","volume":"332","author":"Duley","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib61","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/bmj.39532.543947.BE","article-title":"Diagnostic accuracy of urinary spot protein:creatinine ratio for proteinuria in hypertensive pregnant women: systematic review","volume":"336","author":"C\u00f4t\u00e9","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib62","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/bmj.38380.674340.E0","article-title":"Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies","volume":"330","author":"Duckitt","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib63","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib64","first-page":"CD001449","article-title":"Drugs for treatment of very high blood pressure during pregnancy","volume":"3","author":"Duley","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib65","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2165\/00002018-200124060-00004","article-title":"Treating hypertension in women of child-bearing age and during pregnancy","volume":"24","author":"Magee","year":"2001","journal-title":"Drug Safety"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib66","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1177\/0961203308090027","article-title":"Lupus and pregnancy: ten questions and some answers","volume":"17","author":"Ruiz-Irastorza","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib67","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/rheumatology\/kei159","article-title":"The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and\/or the antiphospholipid syndrome","volume":"45","author":"Le Thi Huong","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bpobgyn.2011.10.006_bib68","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1503\/cmaj.070430","article-title":"Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis","volume":"178","author":"Cnossen","year":"2008","journal-title":"Can Med Assoc J"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693411001556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693411001556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T11:48:01Z","timestamp":1593258481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693411001556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S1521693411001556"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2011.10.006","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}